Drugs / Alum
last change Aug 2023 re-read 2 minutes ago

Alum

Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1 · a red edge is where a trial was stopped

2024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT05903339 Aug 2023 → Dec 2026 expected HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Active not recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Alum ClinicalTrials.gov intervention name — accepted as the source's own label NCT05903339